In the landmark SURMOUNT-1 trial, participants receiving the highest dose of tirzepatide lost an average of 22.5% of their body weight over 72 weeks, making it one of the most effective pharmaceutical weight loss interventions available (Jastreboff et al., 2022, New England Journal of Medicine )
A study in the Journal of Clinical Endocrinology & Metabolism revealed that men on TRT alone lost an average of 11 pounds of fat and gained 9 pounds of muscle over 18 months
That one often flies under the radar, even though its very real
Roughly 90 per cent of drugs that show promise in animals ultimately fail in human trials
If you were relying on Amino Asylum for your semaglutide supply , you are not alone in scrambling for answers right now
Importantly, BPC-157 is not intended for human or animal use